Oncology Institute, Inc.

The Oncology Institute, Inc. (Nasdaq: TOI) is a value-based oncology care company that completed its business combination with DFB Healthcare Acquisitions Corp., a blank-check vehicle sponsored by DFB & Co., in late 2021. On December 14, 2021, the combined company filed a Form 10-K/A with the SEC, an amended annual report reflecting updated disclosures following the close of the de-SPAC transaction. The SPAC conducted its IPO in 2021 and targeted the healthcare sector, specifically community-based oncology services. TOI continues to trade on Nasdaq under its current ticker. Sign up for SpacDesk to access full filing history, sponsor profiles, and deal analytics on TOI and thousands of other SPAC transactions.